SEC 13F Intelligence

Ia Global Asset Management Inc. / REGN

Ia Global Asset Management Inc.’s Regeneron Pharmaceuticals Position

Does Ia Global Asset Management Inc. own Regeneron Pharmaceuticals (REGN)? Yes — 20.6K shares worth $16M (+0.23% of its 13F portfolio) as of Q1 2026, down from 21.0K shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
20.6K
% of Portfolio
+0.23%
Quarters Held
12
currently held

Position History REGN

Reported value by quarter
Q2 ’23: $7MQ2 ’23Q3 ’23: $7MQ4 ’23: $8MQ4 ’23Q1 ’24: $12MQ2 ’24: $11MQ2 ’24Q3 ’24: $14MQ4 ’24: $8MQ4 ’24Q1 ’25: $12MQ2 ’25: $10MQ2 ’25Q3 ’25: $11MQ4 ’25: $16MQ4 ’25Q1 ’26: $16Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202620.6K$16M+0.23%
Q4 202521.0K$16M+0.21%
Q3 202520.2K$11M+0.16%
Q2 202519.2K$10M+0.15%
Q1 202519.2K$12M+0.21%
Q4 202411.6K$8M+0.15%
Q3 202413.2K$14M+0.24%
Q2 202410.6K$11M+0.21%
Q1 202412.8K$12M+0.25%
Q4 20239.6K$8M+0.20%
Q3 20238.9K$7M+0.19%
Q2 20239.4K$7M+0.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ia Global Asset Management Inc.’s full portfolio or all institutional holders of REGN.